IREDA Share Price in Focus: Posted Double Digit Growth in Revenue and PAT During Q4FY25

On April 16, 2025, IREDA shares price are in focus as the state-owned renewable project financing company released its results for the quarter (Q4FY25) and year ended March 31, 2025 (FY25). Indian Renewable Energy Development Agency Ltd. (IREDA) recorded significant growth across key financial metrics.

IREDA Q4FY25 Result

IREDA delivered strong year-on-year growth across key financial metrics in Q4 FY2024 -25. Profit After Tax (PAT) rose by 49% to ₹502 crore, while Profit Before Tax (PBT) increased by 31% to ₹630 crore. Revenue from operations saw a robust 37% jump, reaching ₹1,904 crore. The company’s net worth improved by 20% to ₹10,266 crore, and the loan book expanded by 28%, standing at ₹76,281 crore.

IREDA Posted Growth in FY25

The company reported a strong financial performance in FY2024- 25, marked by significant year-on-year growth. Profit After Tax (PAT) rose by 36% to ₹1,699 crore, while Profit Before Tax (PBT) increased by 25% to ₹2,104 crore. Revenue from operations climbed 36% to ₹6,742 crore. The company’s net worth stood at ₹10,266 crore, reflecting a 20% increase, and the loan book expanded by 28% to ₹76,282 crore.

Management Take on Q4FY25 Earnings

Commenting on the results, Shri Pradip Kumar Das, CMD, IREDA, said, “IREDA’s sustained growth in revenue, profitability, and loan book underscores our strategic focus towards financing India’s renewable energy ambitions. We remain committed to being the enabler of India’s green energy transition through innovative financial solutions and strategic partnerships.”

Shri Das also expressed his appreciation for Team IREDA for their unwavering dedication and excellence in achieving these milestones. He further extended his gratitude to Shri Pralhad Joshi, Hon’ble Union Minister of New & Renewable Energy, Consumer Affairs and Food & Public Distribution; Shri Shripad Naik, Hon’ble Minister of State for Power and New & Renewable Energy; Ms. Nidhi Khare, Secretary, MNRE; other senior officials of MNRE and other ministry; and the Board of Directors for their continued support and invaluable guidance.

On April 15, IREDA share price closed at ₹167.10, reflecting a rise of 8.40% on BSE. During the day, IREDA touched the day high of ₹168.85.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Are You Holding SGB 2019-20 Series V: Premature Redemption on April 15

Investors holding the Sovereign Gold Bond (SGB) 2019-20 Series V now have the option to redeem their bonds early, with the redemption price set at ₹9,069 per gram. This follows the SCB’s first premature redemption date on Tuesday, April 15, 2025. 

Since its launch on October 15, 2019, at ₹3,788 per gram, the SGB has yielded a return of 139% over 5.5 years, excluding the annual interest payout. 

It’s important to note that the 2.5% annual interest, paid semi-annually, further enhances the returns for those who choose to hold the bond until maturity, making the overall investment even more profitable. 

Why is Early Redemption Allowed? 

According to the rules of the Sovereign Gold Bond Scheme, investors can redeem their bonds after five years from the date of issue. 

While the bonds have a full maturity period of eight years, ending on October 15, 2027, the early redemption option offers flexibility for investors who want to cash out early or need liquidity. 

How is the Redemption Price Determined? 

The redemption price is based on the average closing prices of 999 purity gold for the last three working days before the redemption date, as published by the India Bullion and Jewellers Association (IBJA). For today’s redemption, the price has been set at ₹9,069 per gram, derived from the average closing prices on April 8, 9, and 11, 2025. 

About SGBs 

SGBs are government-backed bonds that provide returns linked to the price of gold. With the ongoing rise in domestic gold prices, the Union Budget 2025 announced the cessation of new Sovereign Gold Bond issuances. However, existing bonds will continue to be active and can be redeemed according to their scheduled or eligible early redemption dates. 

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing. 

Capitalmind Financial, Jio BlackRock, and Pantomath Capital Advisors to Launch MF Business

The capital market regulator, the Securities and Exchange Board of India (SEBI) has recently given NOD to 3 new players Capitalmind Financial, Jio BlackRock, and Pantomath Capital Advisors to launch their mutual fund businesses in the coming months.

All these mentioned companies have already received in-principal approval. Capitalmind Financial has even received final approval to launch its schemes, while the Jio BlackRock and Pantomath Capital Advisors are still awaiting the same.

Management Comments in News Reports

Deepak Shenoy, Founder of Capitalmind Financial Services, shared that the newly approved fund house plans to start with active equity schemes, followed by debt and hybrid asset classes. He also highlighted that Capitalmind will apply its data-driven, quantitative approach for stock selection, a method already used in their PMS and AIF schemes. The company currently manages over ₹2,000 crores in its PMS and AIF businesses.

Prasanna Pathak, Managing Partner at Pantomath Capital Advisors, mentioned that the AMC plans to launch a flexi-cap fund first once it receives final approval. The firm also intends to introduce a liquid fund and several hybrid funds, including balanced advantage and multi-asset allocation funds. In the long run, Pantomath plans to enter the SIF market, leveraging its background in PMS and AIFs.

Currently, Pantomath Capital manages ₹4,000 crores across three private equity Cat II AIFs and a ₹250 crore PMS scheme. Prasanna aims to bring a private equity-style approach to mutual funds, which he believes could offer a competitive advantage over other AMCs.

Also Read: Upcoming NFO This Week: Opening From April 7, 2025

Growing Indian Mutual Fund Industry

The Average Assets Under Management (AAUM) of the Indian Mutual Fund industry for March 2025 stood at ₹66,70,186 crore, while the Assets Under Management (AUM) as of March 31, 2025, reached ₹65,74,287 crore. Over the past decade, the industry has witnessed significant growth, with AUM increasing more than six-fold from ₹10.83 trillion on March 31, 2015, to ₹65.74 trillion by March 31, 2025.

In just 5 years, from March 31, 2020, to March 31, 2025, the AUM more than doubled, rising from ₹22.26 trillion to ₹65.74 trillion. The Indian mutual fund industry’s growth trajectory has been remarkable, crossing key milestones along the way—₹10 trillion in May 2014, ₹20 trillion in August 2017, and ₹30 trillion in November 2020—culminating in the ₹65.74 trillion mark as of March 2025.

Ensure steady returns with systematic withdrawals! Estimate your withdrawals with our SWP Calculator and manage your finances seamlessly.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Mutual Fund investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Nifty 50 Continued Gaining Streak for 2nd Straight Session: All Sectors in Green

Continuing its upward momentum for the 2nd consecutive session, the Indian stock market opened with a significant gap higher in the early hours of Tuesday, April 15, 2025. The Nifty 50 index opened at 23,368, reaching its intraday high, but it struggled to maintain those elevated levels. Nevertheless, during its ascent to Tuesday’s peak, Nifty experienced a 969-point rally over the past two sessions. At 12:50 PM, Nifty 50 traded 2.24% up at 23,339.60.

All Sectors in Green

All the sectoral indices on NSE were trading in green with Nifty Realty, Nifty Auto gained the most with a rise of 4.49% and 3.44%, respectively.

Why is the Indian Stock Market Gaining Today?

Experts believe that the rise in the Indian stock market is largely driven by an unexpected shift in Trump’s tariff policy. They point to several key factors, including the US bond market tracking the performance of US stocks, the ongoing trade war moving toward negotiations, the weakening of the US dollar, contrasting views between Donald Trump and the US Fed Chairman, and the optimistic outlook of the RBI on Indian inflation. These elements have collectively boosted sentiment on Dalal Street in the past two trading sessions.

 

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Mid-Day Top Gainers and Losers on April 15, 2025: IndusInd Bank and Shriram Finance Led Gainers

On April 15, 2025, as of 12:20 PM, the BSE Sensex was up 2.23% at 76,830.58, while the Nifty 50 was up 2.24% at 23,339.30. The mid-day top gainers and losers for the day are:

Mid-Day Top Gainers 

Symbol Open High Low LTP %chng
INDUSINDBK 705 741 693.05 734.45 6.52
SHRIRAMFIN 651.95 669.8 649.15 667.8 4.54
TATAMOTORS 614 628.3 612.65 621.7 4.48
ADANIPORTS 1,200.00 1,225.90 1,179.00 1,215.80 4.4
LT 3,180.00 3,264.90 3,176.10 3,251.80 4.36

Here’s a brief market update based on the top gainers:

IndusInd Bank

IndusInd Bank shares have surged by over 6.5%, reaching a high of ₹741, driven by strong investor sentiment in the banking sector.

Shriram Finance

Shriram Finance shares were up by nearly 4.5%, the stock has risen to ₹667.8, reflecting positive movement in the finance and lending market.

Tata Motors

With a gain of 4.48%, Tata Motors is seeing increased momentum, reaching ₹621.7 on the back of strong auto sector performance.

Adani Ports

Adani Ports shares rose by 4.4%, reaching ₹1,215.80, as it continues to benefit from growth in port and logistics activities.

Larsen & Toubro

Larsen & Toubro shares have gained 4.36%, hitting ₹3,251.80, driven by optimism around the infrastructure and construction sectors.

Mid-Day Top Losers

Symbol Open High Low LTP %chng
ITC 429.2 429.2 419 421.2 -0.08
HINDUNILVR 2,400.00 2,400.00 2,345.20 2,365.00 -0.05

Here’s a brief market update on the top losers:

ITC

ITC shares opened at ₹429.2 and dipped to ₹419, showing a decline of 0.08%.

Hindustan Unilever

Starting at ₹2,400.00, HUL shares dropped to ₹2,345.20, recording a 0.05% loss, with the stock currently at ₹2,365.00.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Tata IPL 2025: How Experienced Players Compare to Large Cap Stocks?

Over the years, the Indian Premier League (IPL) has evolved into one of the most lucrative and thrilling cricket tournaments in the world. The tournament has given rise to young stars and breakout performances over the past years, but there’s one constant that has remained pivotal to every team’s success—experienced players.

In the upcoming Tata IPL 2025, experienced players are more valuable than ever, and in many ways, they can be compared to large-cap stocks in the stock market. Let’s explore why experienced players are similar to stable and reliable investments.

Reliability Amidst Pressure

Large Cap Stocks are known for their ability to remain stable even in volatile market conditions. Similarly, experienced IPL players bring a level of calm and stability to a team when the pressure is at its peak. They have been in these situations countless times and know how to keep their cool, leading their teams with resilience and experience.

The on-field maturity of experienced players becomes invaluable when the stakes are high, much like how Large Cap Stocks standstill in case of heightened volatility.

Consistent Performance Over Time

Another characteristic of Large Cap Stocks is their ability to consistently deliver returns over time. In the same vein, experienced IPL players are often known for their long-term consistency. These players bring in decades of experience, having honed their skills across various conditions, and they know how to adapt their game to ensure they remain competitive.

Leadership and Mentoring

Large-cap stocks are considered a safe bet due to their stability and long-term growth potential, offering a sense of security to investors, especially in the falling market. Similarly, experienced players provide leadership and mentoring to younger players, ensuring the team’s success is not just based on individual brilliance but collective growth. Their ability to guide younger players, share knowledge, and mentor them is invaluable, just as long-term investors look to their Large Cap Stocks for stability and growth over time.

The Longevity Factor

Large Cap Stocks are known for their ability to provide returns over extended periods. Similarly, many experienced players in the IPL have shown that their longevity in the game allows them to deliver top-notch performances continuously. Their fitness, adaptability, and ability to read the game enable them to keep playing at the highest level for several years.

Marketability and Brand Value

Just like large-cap stocks are highly sought after by investors for their reputation and market position, experienced IPL players are valuable off the field as well. Their brand value, marketability, and fan following often transcend the cricket field. In the world of IPL, they are the face of the team, driving sponsorships, fan engagement, and merchandise sales.

Also Read: Tata IPL 2025: Duck or Century? Understanding Market Volatility and Risk Management

Conclusion

The most effective teams will recognise the importance of experienced players and include them in their frameworks. Just as large-cap stocks offer reliability and growth, experienced players contribute steady performance, leadership, and mentorship. They are the pillars of the team, providing guidance and nurturing emerging talent.

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

IREDA Share Price Zoomed Over 5% Ahead of Q4FY25 Results on April 15

On April 15, 2025, IREDA share price rose over 5% in the morning trade, reaching a day high of 161.90 at 10:20 AM. The gain in IREDA share price is ahead of its scheduled Q4FY25 earnings today, April 15.

IREDA Business Update for FY25

The provisional business performance of IREDA for the fiscal year ending on March 31, 2025, shows notable growth across key metrics. Loan sanctions amounted to ₹47,453 crore, reflecting a 27% increase compared to ₹37,354 crore in the previous year. Loan disbursements also saw a 20% rise, reaching ₹30,168 crore, up from ₹25,089 crore in 2024. Additionally, the loan book outstanding at the end of the year stood at ₹76,250 crore, marking a 28% growth from ₹59,698 crore the year before.

Signing of ECB Facility

In March 2025, Indian Renewable Energy Development Agency Limited (IREDA) signed a Facility Agreement to raise External Commercial Borrowing (ECB) from the State Bank of India’s Tokyo Branch, amounting to JPY 26 billion, which includes a Green Shoe Option of JPY 10 billion. This unsecured, 5 -year facility, with a bullet repayment at maturity, is designed to enhance IREDA’s presence in global markets. The landed cost, after hedging, is expected to remain below 7%, making it a more cost-effective option compared to similar-tenure loans available in the domestic market.

Furthermore, IREDA maintains a strong international credit rating of ‘BBB-’ for long-term and ‘A-3’ for short-term, with a stable outlook, as assigned by S&P Global. This reflects the organization’s commitment to high standards of corporate governance and reinforces its credibility in the international financial markets.

Commenting on the agreement, Shri Pradip Kumar Das, Chairman & Managing Director, IREDA, stated, “This facility enables us to diversify our resource base and optimize costs, enhancing our lending operations to support India’s renewable energy sector. The transaction reflects the strong confidence of global investors in IREDA’s financial stability and growth potential.”

 

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.

Zydus Share Price in Focus: Receive USFDA Approval for Deflazacort Tablets

On April 15, 2025, Zydus share price is on investors’ radar, reaching a day high of ₹892.75 at 09:55 AM, after opening at ₹892.75 on BSE. The gain in Zydus share price follows the company’s release for approval from the United States Food and Drug Administration (USFDA) on April 11, 2025.

Approval from USFDA

The pharma giant, Zydus Lifesciences Limited on April 11, 2025, received final approval from the USFDA to manufacture Jaythari® (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg (USRLD: Emflaza ® Tablets, 6 mg, 18 mg, 30 mg, and 36 mg).

About Deflazacort

Deflazacort is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older. Jaythari® (Deflazacort) will be produced at Doppel Farmaceutici S.r.l., Italy facility. The group now has 424 approvals and has so far filed 492* ANDAs since the commencement of the filing process in FY 2003-04.

Also Read: Zydus Acquires Majority Stake in Amplitude Surgical for €256.8 Mn

Zydus 9M FY25 Performance Overview

For the nine months ended December 31, 2024, the company reported a strong financial performance. Revenue from operations rose by 19% year-on-year to ₹167,136 million. Investments in Research & Development amounted to ₹13,756 million, representing 8.2% of total revenues. The company achieved an EBITDA of ₹49,330 million, marking a 31% increase YoY, with the EBITDA margin improving by 270 basis points to 29.5%.

Net profit for the period stood at ₹33,546 million, up 25% over the previous year. Organic capital expenditure for the nine months was ₹8,938 million. On the balance sheet front, the company maintained a robust financial position with a Net Debt to Equity ratio of -0.14x and a Net Debt to EBITDA ratio of -0.47x as of December 31, 2024. It also held a net cash position (negative net debt) of ₹30,916 million at the end of the period.

Dr. Sharvil Patel, Managing Director of Zydus Lifesciences Limited, said, “We are pleased with the sustained growth momentum across our key businesses that has driven our Q3 performance. Our robust product portfolio execution in the US, market share gain in focused therapy segments and brands in India, and strategic leveraging of our global portfolio in International Markets position us well for future growth. We are on track to achieve our fiscal year 2025 goal of double-digit growth across our key businesses, coupled with improved profitability. Looking ahead, we are strategically building growth levers to ensure sustained success, with patient centricity and quality at the core of our operations.

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.

RBI to Conduct ₹40,000 Crore OMO on April 17: All You Need to Know

On April 11, 2025, the Reserve Bank of India (RBI) announced that it has decided to implement an Open Market Operation (OMO) purchase auction of Government of India securities on a review of current and evolving liquidity conditions. The schedule OMO of worth ₹40,000 crore is to be held on April 17, 2025.

RBI further stated in the release that the said auction is in addition to the previously announced ₹80,000 crore OMO programme, which is scheduled to be conducted in 4 tranches of ₹20,000 crore each on April 3, April 8, April 22, and April 29.

VRR Auction

In a separate move, the RBI announced its plan to conduct a 43-day variable rate repo (VRR) auction on the same day, aiming to inject ₹1.5 trillion into the banking system. So far, the RBI has infused ₹2.9 trillion through open market operations (OMOs) and an additional ₹2 trillion via long-term VRR auctions. As of Thursday, April 10, 2025, the net liquidity in the banking system stood at a surplus of ₹1.8 trillion.

Indian Banking Saw Liquidity Surplus

The Reserve Bank of India (RBI) concluded fiscal year 2025 (FY25) with its most substantial open market operations in the past 4 years, highlighting its proactive approach to liquidity management. By the end of March 2025, the Indian banking system recorded a liquidity surplus of ₹89,400 crore, a sharp reversal from the ₹3.3 lakh crore deficit seen in January. This notable shift underscores the RBI’s assertive measures to stabilize the financial system.

The central bank’s liquidity support has become especially important amid an uneven economic recovery in India, marked by persistent inflationary pressures, a slowdown in industrial production, and global economic headwinds dampening business confidence. Adding to the uncertainty, geopolitical tensions—particularly the ongoing Russia- Ukraine conflict—continue to roil global markets, which in turn has impacted India’s financial landscape.

Conclusion

The Reserve Bank of India’s recent actions—including a series of large-scale OMO purchases and VRR auctions—highlight its continued commitment to actively managing systemic liquidity and supporting financial stability amid evolving economic challenges

Also Read: RBI Announces Fresh Open Market Operations of ₹80,000 Crore to Boost Liquidity

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.

Upcoming Q4FY25 Earnings This Week: IREDA, Wipro, Infosys and More Set to Release Earnings

The Q4FY2025 earnings season has commenced with the release of TCS Q4FY2025 results on April 10, 2025. The IT giant TCS posted subdued earnings with growth in earnings and pressure on margins. The week commencing from April 14 to April 19 is set to see the release of earnings of various companies, which are listed below

IREDA

The Indian Renewable Energy Development Agency (IREDA) is set to release Q4 results on Tuesday, April 15. IREDA reported a 26.8% year-on-year increase in net profit for Q3FY25, posting ₹425.4 crore compared to ₹335.5 crore in the same quarter last year. On a sequential basis, profit after tax rose 10% from ₹388 crore in Q2FY25. Revenue from operations surged over 35% year-on-year to ₹1,698.45 crore.

GM Breweries

The manufacturer of alcoholic beverages has scheduled the release of Q4FY25 results for April 15. GM Breweries posted a 5.7% year-on-year increase in revenue to ₹166 crore for the quarter ending December 31, 2024, up from ₹157 crore a year ago. However, net profit declined by 4.3% to ₹22 crore. EBITDA rose 18% to ₹30 crore from ₹25.3 crore, with EBITDA margins improving to 18% from 16% in the prior-year quarter.

Wipro

Wipro marks April 16, 2025, as the earnings release date for Q4FY25. Wipro reported Q3FY25 revenue of $2,629.1 million, matching expectations, with constant currency growth of 0.1%, surpassing its own forecast of 0% to -2%. In rupee terms, revenue came in at ₹22,285 crore, a 0.4% increase QoQ. EBIT rose 4.5% QoQ to ₹3,899 crore, with the EBIT margin expanding to 17.5% from 16.8%. However, large deal wins dropped 35% sequentially to $961 million. For Q4, the company expects revenue between $2,602–$2,655 million, implying a -1% to 1% growth in constant currency.

Infosys

India’s 2nd largest IT services major, Infosys, will declare its Q4FY25 results on April 17. Infosys recorded an 11.4% year-on-year rise in net profit for Q3FY25, reaching ₹6,806 crore, while revenue grew 7.5% to ₹41,764 crore. The company raised its FY25 revenue growth guidance to 4.5%-5%.

ICICI Bank, ICICI Lombard General Insurance and ICICI Prudential Life Insurance

This week, three ICICI Group companies are scheduled to report Q4 results. The two insurance arms will announce earnings on Tuesday, April 15, while ICICI Bank, the country’s second-largest private sector lender, will report on Saturday, April 19.

 

 

 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.